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Summary 1	
 2	
There is great interest in the role epigenetic variation induced by non-genetic exposures may 3	
play in the context of health and disease. In particular, DNA methylation has previously been 4	
shown to be highly dynamic during the earliest stages of development and is influenced by in 5	
utero exposures such as maternal smoking and medication. In this study we sought to 6	
identify the specific DNA methylation differences in blood-associated prenatal exposures 7	
including birth weight, gestational age and maternal smoking. We quantified neonatal 8	
methylomic variation in 1,263 infants using DNA isolated from a unique collection of archived 9	
blood spots taken shortly after birth (mean = 6.08 days; sd = 3.24 days). An epigenome-wide 10	
association study (EWAS) of gestational age and birth weight identified 4,299 and 18 11	
differentially methylated positions (DMPs) respectively, at an experiment-wide significance 12	
threshold of P < 1x10-7. Our EWAS of maternal smoking during pregnancy identified 110 13	
DMPs in neonatal blood, replicating previously reported genomic loci including AHRR. 14	
Finally, we tested the hypothesis that DNA methylation mediates the relationship between 15	
maternal smoking and lower birth weight, finding evidence that methylomic variation at three 16	
DMPs may link exposure to outcome. These findings complement an expanding literature on 17	
the epigenomic consequences of prenatal exposures and obstetric factors, confirming a link 18	
between the maternal environment and gene regulation in neonates. 19	
 20	
 21	
  22	
	 4	
Main Text 1	
 2	
Introduction 3	
Epigenetic mechanisms developmentally regulate gene expression via modifications to DNA, 4	
histone proteins, and chromatin. Because epigenetic processes can be influenced by 5	
exposure to a range of external environmental factors (1-4) and also by genetic variation(5, 6	
6) , there is great interest in the role that epigenetic variation may play in the context of 7	
health and disease(7) . As epigenetic marks are inherited mitotically in somatic cell lineages, 8	
they provide a mechanism by which disruption early in life can be propagated through 9	
development, producing long-term phenotypic variation. DNA methylation is the best-10	
characterized epigenetic modification, stably influencing gene expression via the disruption 11	
of transcription factor binding and recruitment of methyl-binding proteins that initiate 12	
chromatin compaction and gene silencing. Despite being often regarded as a mechanism of 13	
transcriptional repression, DNA methylation is associated with both increased and 14	
decreased gene expression (8), and also influences other genomic functions including 15	
alternative splicing and promoter usage (9).  16	
 17	
The availability of high-throughput profiling methods for quantifying DNA methylation across 18	
the genome at single base resolution in large numbers of samples has enabled researchers 19	
to perform epigenome-wide association studies (EWAS) aimed at identifying methylomic 20	
variation associated with environmental exposures and disease (7). Although these studies 21	
are inherently more complex to design and interpret than genetic association studies (10-22	
12), recent analyses have documented differences in DNA methylation in neonates and 23	
children following exposure to a wide range of environmental factors during gestation, 24	
including maternal smoking, maternal diet and pollution (2, 3, 13).  There is also interest in 25	
the role that DNA methylation may play as mediator through which environment exposures 26	
can influence long-term health outcomes. For example, there is evidence that the causal 27	
relationship between maternal smoking during pregnancy and low birth weight is mediated 28	
through differences in DNA methylation at specific loci across the genome (14, 15). While 29	
noteworthy, these analyses have been based on moderate samples sizes, have generally 30	
not replicated the same loci, and may have overestimated mediation effects because of 31	
invalid assumptions and misclassification of the exposure (16).  32	
 33	
Another active area of research concerns the utility of DNA methylation as a biomarker for 34	
clinical monitoring and screening. The potential of a DNA methylation based predictor has 35	
been most robustly demonstrated for age, with a number of algorithms available, referred to 36	
as “epigenetic clocks” (17-19). There is particular interest in how measures of age derived 37	
	 5	
from DNA methylation data correlate with actual chronological age, and also whether 1	
"accelerated” epigenetic age predicts aging phenotypes such as mortality, cancer and 2	
dementia (18, 20, 21). There is also interest in whether other exposures (or phenotypes) can 3	
be inferred from an epigenetic profile. The development of an epigenetic biomarker using 4	
neonatal blood samples might enable the evaluation of in utero exposures, which are hard to 5	
measure objectively, and could be a useful prospective predictor for future health outcomes. 6	
To this end, a biomarker of maternal smoking during pregnancy was recently developed 7	
using cord blood samples that demonstrates high specificity (97%) - but only moderate 8	
sensitivity (58%)(22) - demonstrating the potential application of such approaches. Because 9	
DNA methylation is known to be highly dynamic during the earliest stages of development 10	
(23, 24), insults during this period may have important functional consequences or impact 11	
upon disease susceptibility later in life. Of note, several psychiatric disorders are 12	
hypothesised to have important neurodevelopmental origins (25-27) and have been 13	
associated with a number of prenatal and perinatal risk factors. For example, 14	
epidemiological studies have reported a higher risk of autism in those born with a low birth 15	
weight (28, 29) or born pre-term (30). Although DNA methylation predictors for age (18) and 16	
smoking (31) developed in childhood or adult samples have been shown to work reasonably 17	
well, methods developed specifically in either cord blood or neonatal samples have superior 18	
performance at these ages (19).  19	
 20	
In this study, we first sought to identify specific patterns of DNA methylation in neonatal 21	
blood samples associated with three obstetric and neonatal influences measured in the 22	
same individuals: birth weight, gestational age and exposure to maternal smoking. We 23	
subsequently use our results to explore whether variable DNA methylation mediates the 24	
relationship between maternal smoking and low birth weight. We attempted to address these 25	
questions by quantifying methylomic variation in 1,263 infants using DNA isolated from 26	
archived blood spots taken shortly after birth (mean = 6.08 days; sd = 3.24 days) originally 27	
profiled in a case-control study of autism (32). Although we cannot exclude the role of DNA 28	
methylation changes occurring during the first few days after birth, our study extends 29	
previous research into the early-life epigenome that have either used samples collected later 30	
in childhood or from cord blood (13, 24, 33), which has the limitation that it may be 31	
contaminated by maternal blood (34, 35). Our findings complement the expanding literature 32	
on the epigenomic consequences of prenatal exposures and obstetric factors, confirming a 33	
link between the maternal environment and markers of gene regulation in neonates.     34	
	 6	
Methods 1	
Overview of the MINERvA cohort 2	
A description of the MINERvA cohort was recently published alongside extensive details of 3	
the profiling of DNA methylation and data quality control steps (32). Briefly, MINERvA 4	
contains a subset of 1,316 samples from the iPSYCH autism spectrum disorder case-control 5	
sample (36). All perinatal data used for case-control sample matching, plus additional 6	
information on birth weight and maternal smoking were obtained from the Danish Medical 7	
Birth Register or the Central Person Register. An overview of the demographic 8	
characteristics of the MINERvA cohort is given in Supplementary Table 1. Of note, cases 9	
and controls were matched as closely as possible. Although rates of maternal smoking were 10	
higher in autism cases, there was no significant difference in birth weight between autism 11	
cases and controls. 12	
 13	
DNA methylation profiling in MINERvA 14	
Neonatal dried blood spot samples collected on standard Guthrie cards and stored within the 15	
Danish Neonatal Screening Biobank (37) were retrieved as part of the iPSYCH study (36). 16	
Neonatal DNA extractions and DNA methylation quantification was performed at the Statens 17	
Serum Institut (SSI, Copenhagen, Capital Region, Denmark). Briefly, DNA was converted 18	
with sodium bisulfite using the EZ-96 DNA Methylation Kit (Zymo Research, California, 19	
United States of America) and DNA methylation was quantified across the genome using the 20	
Infinium HumanMethylation450k array (“450K array”) (Illumina, California, United States of 21	
America). After a stringent quality control process (outlined in (32)), 1,263 samples (96.0%) 22	
were included for subsequent analysis. Normalization of the DNA methylation data was 23	
performed used the dasen() function in the wateRmelon package(38). For each sample, we 24	
derived nine additional variables from the DNA methylation data using established 25	
algorithms: DNA methylation age(18), gestational age(19), smoking(31), and six blood cell 26	
composition variables(39, 40). Our previous publication on these data demonstrated that the 27	
smoking score, despite being trained in adults who smoked, correlated with reported 28	
maternal smoking status from the registry data (32). All quality control and statistical 29	
analyses were performed using the R statistical environment version 3.2.1 (41). 30	
 31	
Epigenome-wide association analyses (EWAS) 32	
We performed an EWAS of three obstetric/neonatal factors that were robustly measured in 33	
our cohort. First, to identify DNA methylation sites associated with birth weight (measured in 34	
grams (g)) and gestational age (measured in weeks), a linear model was fitted for each DNA 35	
methylation site with DNA methylation as the dependent variable, both birth weight and 36	
gestational age as independent variables, and a set of possible confounders as covariates: 37	
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sex, experimental array number (i.e., chip), days to sampling, maternal smoking (using the 1	
continuous variable estimated from the DNA methylation data) and six derived cell 2	
composition variables. Given the strong concordance between the findings of our maternal 3	
smoking EWAS and those of previous EWAS analyses of smoking (see Results), we used 4	
the derived maternal smoking score to make up for missing data in the registry data and 5	
maximize power for analyses. To compare results between autism spectrum disorder (ASD) 6	
cases and controls, we tested for a heterogeneous effect by including an interaction term 7	
between i) birth weight and case control status, and ii) gestational age and case control 8	
status. In these interaction models, ASD case control status was also included as a main 9	
effect. Second, to identify differentially methylated positions (DMPs) associated with registry-10	
reported maternal smoking exposure, a linear model was fitted for each DNA methylation 11	
site with DNA methylation as the dependent variable, and a binary indicator variable for in 12	
utero exposure to smoking in addition to a set of possible confounders as covariates: sex, 13	
birth weight, gestational age, experimental array number (i.e. chip), and six derived blood 14	
cell composition variables. Significant DMPs were identified at an experiment-wide multiple 15	
testing adjusted threshold of P < 1x10-7. Clustering of significant DMPs into loci was 16	
performed by taking each significant site in turn, starting with the one with the smallest p 17	
value (referred to as the index association), identifying all other significant sites within 5kb 18	
upstream and downstream and merging these into a single locus. Any less significant (i.e. 19	
larger p value) DMPs merged with an index site were then excluded from consideration as 20	
an index association. This procedure was repeated until all significant DMPs were either 21	
merged with a more significant association or considered as an index site. Conditional 22	
analyses were performed within loci with at least two DMPs by repeating the original 23	
association analysis for the secondary signal (i.e. the less significant site) including the most 24	
significant DNA methylation site in that loci as an additional covariate. 25	
 26	
Replication dataset 27	
The Accessible Resource for Integrated Epigenomic Studies (ARIES; 28	
http://www.ariesepigenomics.org.uk) cohort comprises of a sub-sample of 1018 ALSPAC 29	
(http://www.bristol.ac.uk/alspac/) child–mother pairs with Illumina 450K array DNA 30	
methylation data generated from cord blood (n = 914), and whole blood at two time points 31	
during childhood (age 7 (n = 973) and age 15 or 17 years (n = 974)). The results used in this 32	
manuscript are taken from the gestational age and birth weight EWAS performed by Simpkin 33	
et al(24) and presented in Supplementary Table 1 and Table 3 published alongside the 34	
manuscript.  35	
 36	
Mediation analyses 37	
	 8	
Mediation analyses were performed using the criteria outlined by Baron and Kenny(42) and 1	
the Sobel test(43). We considered DMPs associated with registry-reported maternal smoking 2	
without controlling for birth weight in our dataset (n = 143 DMPs) and tested whether the 3	
following criteria were met for each site:  4	
(i) smoking significantly correlated with DNA methylation level (P < 1x10-7; sex, 5	
gestational age, batch and cell composition included as covariates). 6	
(ii) smoking significantly correlated with birth weight without adjusting the model 7	
for DNA methylation (sex and gestational age included as covariates). 8	
(iii) DNA methylation significantly correlated with birth weight (P < 1x10-7; sex, 9	
gestational age, batch and cell composition included as covariates). 10	
(iv) the association between smoking and birth weight decreased upon addition 11	
of DNA methylation to the model (i.e. p value got larger; sex, gestational age, 12	
batch and cell composition included as covariates). 13	
(v) the Sobel test gave P < 3.50 x10-4 (corrected for 143 DMPs considered, 14	
implemented through the R bda package (https://cran.r-15	
project.org/web/packages/bda/index.html). 16	
 17	
DMPs meeting the criteria for mediation were taken forward for a sensitivity analysis that 18	
accounted for misclassification of the exposure following the method outlined in Valeri et 19	
al(16) using the SIMEX procedure(44). Our naive outcome regression model between birth 20	
weight and registry-reported maternal smoking exposure and naïve mediator regression 21	
model between DNA methylation and birth weight included covariates for gestational age, 22	
sex, cellular composition and experimental chip.  The naive direct effect is then the 23	
coefficient from the outcome regression model for maternal smoking and the naïve indirect 24	
effect is the naive direct effect multiplied by the estimated coefficient for maternal smoking 25	
from the mediator regression. Applying SIMEX to outcome and mediator regressions, we 26	
obtained corrected estimates of the regression parameters which were then used to 27	
calculate the direct and indirect effects. We set the parameter for specificity to 1.0 as we 28	
assume that all smokers are likely to have reported correctly, whereas we assume that some 29	
non-smokers will have reported incorrectly therefore the sensitivity parameter was set to 0.6. 30	
A bootstrap method was used to estimate the standard errors of the estimated effects and 31	
their 95% confidence intervals.   32	
  33	
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Results 1	
Blood cell proportions derived from DNA methylation data correlate with birth weight and 2	
gestational age in neonatal blood.  3	
Our first analyses aimed to explore whether measures derived from DNA methylation data at 4	
birth (i.e. gestational age and blood cell composition estimates) are associated with birth 5	
weight. We previously demonstrated the robustness of DNA methylation data derived from 6	
neonatal blood spots by implementing two DNA methylation clock algorithms to derive 7	
estimates for i) age in years(18) and ii) gestational age in weeks(19) for each sample. As 8	
expected, we observed a strong positive correlation between estimated and actual 9	
gestational age (r = 0.602, 95% CI = (0.566, 0.636), P = 3.80x10-125) and a weaker positive 10	
correlation between estimated chronological age and actual gestational age (r = 0.139, 95% 11	
CI = (0.0849, 0.193), P = 6.52x10-7)(32). We next extended these analyses to investigate 12	
how birth weight correlates with these predicted ages and whether variable birth weight 13	
explains the difference between predicted age (derived from DNA methylation data) and 14	
actual age. Birth weight was significant correlated with predicted measures of both age (r = 15	
0.119, 95% CI = (0.0638, 0.173), P = 2.40x10-5; Supplementary Figure 1A) and gestational 16	
age (r = 0.333, 95% CI = (0.0849, 0.193), P = 5.15x10-34; Supplementary Figure 1B). 17	
However, the age acceleration residuals - which are adjusted for reported gestational age - 18	
are not significantly associated with birth weight (P > 0.05, Supplementary Figure 1C, 1D) 19	
indicating that variation in birth weight does not explain the difference between reported 20	
gestational age and predicted age and that other pregnancy and/or obstetric factors may be 21	
influencing derived age estimates. Given the difficulties in collecting large volumes of blood 22	
from neonates, little is known about blood cell-type variation at this stage of life. We 23	
therefore explored how predicted cellular composition variables derived from the DNA 24	
methylation data (see Methods) correlate with birth weight and reported gestational age. 25	
Gestational age was positively correlated with the estimated proportions of CD8 T- cells (r = 26	
0.140; 95% CI = (0.0857,0.194), P = 5.63x10-7) and natural killer cells (r = 0.0722, 95% CI = 27	
(0.0171,0.127), P = 0.0103), and negatively correlated with the estimated proportion of B 28	
cells (r = -0.231, 95% CI = (-0.282, -0.178), P = 1.06x10-16) (Supplementary Figure 2). Birth 29	
weight was significantly negatively correlated with the estimated proportion of monocytes (r 30	
= -0.0604, 95% CI = (-0.115, -0.00529), P = 0.0317) and positively correlated with the 31	
estimated proportion of granulocytes (r = 0.0624, 95% CI = (0.00727, 0.117), P = 0.0266) 32	
(Supplementary Figure 3). Given the potential confounding influence of cellular 33	
heterogeneity in EWAS analyses using blood, these derived variables were included in all 34	
subsequent analyses.  35	
 36	
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Birth weight and gestational age are associated with variable DNA methylation in neonatal 1	
blood  2	
To identify DNA methylation sites associated with reported gestational age and birth weight 3	
we next performed an EWAS across all Illumina 450K array sites on the autosomes and X-4	
chromosome (n = 430,676 sites), undertaking the analyses simultaneously to minimise 5	
confounding resulting from the strong correlation between these two obstetric variables (r = 6	
0.491,95% CI = (0.448,0.532), P = 1.14x10-77; Supplementary Figure 4). In total, we 7	
identified 18 differentially methylated positions (DMPs) associated with birth weight (Figure 8	
1; Supplementary Figure 5 and Supplementary Figure 6) and 4,299 DMPs associated 9	
with gestational age (Figure 1; Supplementary Figure 7 and Supplementary Figure 8) at 10	
an experiment-wide significance threshold (P < 1x10-7) (Supplementary Tables 2 and 3). 11	
The associated DMPs were characterized by a median shift in DNA methylation of 1.40% 12	
(SD = 0.368%) per kg and 0.406% (SD = 0.275) per gestational week. Seven sites were 13	
significantly associated with both birth weight and gestational age (Table 1). Sensitivity 14	
analyses repeating the EWAS excluding samples from ‘outlier’ individuals born i) before 35 15	
weeks (N = 23) or ii) before 32 weeks (N = 5) revealed high concordance with our primary 16	
analysis (Supplementary Figure 9), suggesting that the results are robust to the presence 17	
of premature individuals.  Although the majority of DMPs associated with increased birth 18	
weight were associated with reduced DNA methylation (66.7%) there was not a significant 19	
bias (sign test P = 0.238) due to the small total number of DMPs identified. In contrast, there 20	
was a highly-significant bias towards increased DNA methylation at sites associated with 21	
older gestational age (73.2%, sign test P = 2.29x10-135). Although this contradicts results 22	
from a previous study using cord blood derived DNA from the ARIES cohort (n = 914) which 23	
identified a smaller number of DMPs that were enriched for sites showing a decrease in DNA 24	
methylation with older gestational age (24), our most significant DMPs are characterised by 25	
reduced DNA methylation with age (Supplementary Table 3) and associations at sites 26	
showing this pattern of change are significantly stronger (Mann-Whitney P = 2.58x10-228). 27	
Furthermore, we find a significant excess of consistent effects between studies indicating 28	
that age-associated changes are similar in cord and neonatal whole blood (Supplementary 29	
Figure 10). Of 148 DMPs associated with gestational age in the ARIES cohort, 146 (98.6%) 30	
had the same direction of effect (sign test P = 6.18x10-41), with 110 being significantly 31	
associated (P < 1x10-7) in both cohorts. We found similar consistency for our EWAS of birth 32	
weight; all 21 DMPs associated with birth weight in the ARIES cohort had the same direction 33	
of effect in our data (sign test P < 2x10-323), with two DMPs being significantly associated (P 34	
< 1x10-7) in both cohorts (Supplementary Figure 10). While the 18 DMPs associated with 35	
birth weight are annotated to distinct genomic loci, the 4,299 DMPs associated with 36	
gestational age are clustered into 3,550 distinct locations with up to 25 additional DMPs 37	
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located within 5kb of the index DMP characterized by the most significant association. 1	
Conditional analyses within each genomic locus containing at least two DMPs (n = 483; 2	
13.6%) revealed evidence for independent secondary signals for 240 DMPs in 193 of these 3	
loci (conditional P < 5x10-5), while 100 DMPs within 66 loci were only associated as a result 4	
of their correlation with the most significant DMP in that loci (conditional P > 0.05; 5	
Supplementary Table 4).  Finally, given the association between both low birth weight and 6	
pre term birth and autism we tested whether the DNA methylation differences we identified 7	
were consistent between individuals who later went on to develop a childhood diagnosis of 8	
autism (n = 629)	and matched controls (n = 634). There were no significant differences 9	
between autism cases and controls for DMPs associated with birth weight (min P = 0.0446) 10	
or for DMPs associated with gestation age (min P = 3.51x10-5) after correcting for the 11	
number of DMPs significant in each analysis (birth weight: P < 0.00278 corrected for 18 12	
DMPs; gestational age: P < 1.16x10-5 corrected for 4,299 DMPs) (Supplementary Table 2 13	
and Supplementary Table 3).  14	
 15	
Maternal smoking influences DNA methylation in neonates at multiple loci 16	
Exposure to tobacco smoke is known to be associated with widespread alterations in DNA 17	
methylation in whole blood (1), and previous analyses have demonstrated that these effects 18	
can be detected in cord blood from neonates exposed to prenatal smoking (13). One 19	
limitation of using cord blood is that DNA methylation estimates can be influenced by 20	
contamination of maternal blood, and we therefore sought to test these whether these 21	
associations were detectable in neonatal whole blood samples. Mothers were asked about 22	
their smoking status at their first prenatal visit, early in the second trimester of pregnancy. 23	
Amongst the mothers of neonates in our cohort, 294 (25.1%) reported smoking during 24	
pregnancy and 879 (74.9%) reported not smoking during pregnancy; we excluded 36 25	
mothers who reported giving up smoking at some time during the pregnancy and 54 mothers 26	
for whom smoking data was not available. First, we assessed whether maternal smoking 27	
influenced derived measures of age generated from DNA methylation data in these samples. 28	
Neither age, gestational age nor age acceleration was associated with in utero exposure to 29	
smoking (Supplementary Figure 11).  Next, we performed an EWAS of maternal smoking 30	
exposure (n = 1,173, controlling for sex, birth weight, gestational age, experimental batch, 31	
and derived cell composition variables), identifying 110 neonatal blood DMPs associated 32	
with maternal smoking (P < 1x10-7) representing 70 discrete genomic loci (Figure 2; 33	
Supplementary Figure 12, Supplementary Table 5). Conditional analyses within each 34	
genomic loci with at least two DMPs (n = 13) identified seven loci where a single DMP was 35	
associated with maternal smoking (conditional P for other sites > 0.05) and four loci 36	
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characterized by secondary semi-independent effects (conditional P for other sites < 5x10-5; 1	
Supplementary Table 6).  There was no significant bias towards a particular direction of 2	
effect (50.9% hypomethylated; 49.1% hypermethylated, sign test P = 0.924) and the median 3	
effect was a difference of 2.28% DNA methylation (SD = 2.19%) (Supplementary Figure 4	
13). There was considerable overlap with DMPs reported in a large EWAS of maternal 5	
smoking performed in cord blood (13) (n = 6,685; Supplementary Figure 14). Of note, 6	
4,847 (84.0%) of the 5,768 DMPs reported by Joubert et al. were characterized by the same 7	
direction of effect (sign test P < 2x10-323) in our analysis of neonatal blood, with 102 meeting 8	
criteria for experiment-wide significance (P < 1x10-7) in both studies. This included previously 9	
reported DMPs associated with tobacco smoking in adults (1, 31) such as AHRR, where five 10	
additional DMPs were clustered with the lead signal at cg05575921 none of which remained 11	
significant in the conditional analysis, GFI1 which had nine DMPs including multiple 12	
independent associations, and MYO1G which had four DMPs with evidence of multiple 13	
independent associations (Supplementary Table 6). These findings confirm that smoking 14	
behaviour by mothers during pregnancy has a profound influence on DNA methylation in 15	
their offspring at birth and in the first few days of life. 16	
 17	
DNA methylation mediates the relationship between maternal smoking and low birth weight   18	
Having established that the DNA methylation signatures associated with prenatal smoking 19	
exposure are robustly detectable in neonatal blood, and that variable DNA methylation is 20	
associated with an established outcome of maternal smoking (45, 46) we next asked 21	
whether methylomic variation might mediate the relationship between maternal smoking in 22	
pregnancy and lower birth weight. Previous attempts to explore this using data from cord 23	
blood have been relatively inconsistent (14, 15), supporting a mediation role for DNA 24	
methylation at non-overlapping DNA methylation sites. We repeated our EWAS of maternal 25	
smoking, excluding birth weight as a covariate, and identified an extended set of 143 DMPs 26	
(Supplementary Table 7) which contained 105 (95.5%) of the 110 DMPs we identified in 27	
the analysis adjusting for birth weight. Mediation analyses, performed using the Sobel test as 28	
(see Methods), showed that DNA methylation at three sites, annotated to three different 29	
genomic loci, met the five criteria set out by Baron and Kenny (42) (see Methods) as 30	
providing evidence for mediating the association between smoking and birth weight 31	
(Supplementary Figure 15; Supplementary Table 7). This included one site (cg09935388) 32	
annotated to GFI1 that has been reported previously (15) and two novel mediation sites 33	
(cg05575921 annotated to AHRR, and cg26889659 annotated to EXOC2) (Table 2). 34	
Because smoking behaviour is prone to misclassification - not only due to smokers claiming 35	
	 13	
to be non-smokers, especially during pregnancy(47), but also because a complex behaviour 1	
is simplified into a dichotomous variable - we repeated the analysis for the three significant 2	
DNA methylation sites estimating the natural direct effect between maternal smoking and 3	
low birth weight (i.e. not via DNA methylation) and the natural indirect effect (i.e. via DNA 4	
methylation) using the SIMEX (simulation and extrapolation) procedure that incorporates 5	
misclassification (44). Stringently accounting for misclassification suggests that the 6	
estimated mediation effect via DNA methylation identified using the Sobel test is potentially 7	
overestimated; although the results robustly support a significant mediation effect for DNA 8	
methylation at cg26889659, under scenarios of more extreme misclassification (see 9	
Methods) the effects of mediation via DNA methylation at cg05575921 and cg09935388 are 10	
no longer significantly different from 0 (Supplementary Table 8).  11	
	 14	
 1	
Discussion 2	
In this study we quantified neonatal variation in DNA methylation in 1,263 infants using 3	
samples isolated from archived blood spots taken shortly after birth. Our study finds that 4	
gestational age, birth weight and maternal smoking are all associated with significant DNA 5	
methylation differences in neonatal blood, with gestational age having the most effects 6	
widespread across the genome. These data add to a growing literature demonstrating that 7	
prenatal and obstetric exposures can influence epigenetic variation in early-life (3, 13, 24, 8	
48-50), providing a potential mechanism linking them to altered gene function and long-term 9	
health and disease outcomes.  10	
Our use of neonatal DNA samples means that we are uniquely positioned to identify 11	
epigenetic variation at birth, avoiding the confounding exposures that could influence the 12	
results from samples collected later in childhood (for example, health and disease, nutrition, 13	
medication, and stress). Although there have been larger studies of prenatal exposures, a 14	
strength of our study is that we profiled whole blood from neonatal infants rather than cord 15	
blood minimizing the contamination of our samples with maternal blood DNA and meaning 16	
our data can be more easily compared to the extensive blood DNA methylation datasets 17	
derived from samples later in life. A limitation of our sampling strategy, however, is that no 18	
blood cell reference DNA methylation datasets specifically for use on neonatal blood are yet 19	
available, likely reflecting the difficulties of obtaining sufficient volumes of neonatal blood for 20	
cell sorting and methylomic profiling. Although there has been much written on the 21	
importance of selecting an appropriate tissue to profile for epigenetic studies(10), the goal of 22	
this study was to identify biomarkers of exposure, and therefore our use of a peripheral 23	
tissue is justified. Furthermore, although blood spots were collected only a few days after 24	
birth (mean = 6.08 days; sd = 3.24 days), it is possible that some postnatal exposure to 25	
passive smoking during the first few days of life could also have influenced our results 26	
although the amount of exposure in ~6 days is likely to be negligible.  27	
As well as identifying specific loci at which DNA methylation is associated with with early-life 28	
factors such as smoking exposure and gestational age, we tested the hypothesis that DNA 29	
methylation mediates established epidemiological relationships between exposures and 30	
outcomes. We explored the association between maternal smoking and lower birth weight, 31	
finding evidence that methylomic variation at several DMPs may be mechanistically involved 32	
in linking exposure (maternal smoking) to outcome (birth weight). While our results are 33	
consistent with previous reports, such analyses can be influenced by misclassification bias 34	
(16). Smoking, in particular is prone to misclassification not only due to participants claiming 35	
	 15	
to be non-smokers when they are in fact smokers, a circumstance known to be worse when 1	
reflecting smoking during pregnancy(47), but also as a result of simplifying a complex 2	
behaviour into a single dichotomous variable representing the entire period of pregnancy. 3	
Given our robust prenatal smoking exposure associations, it is plausible that the mediator in 4	
our analyses - DNA methylation - is in fact a better measure of smoking exposure than self-5	
reported status(16). Of note, applying a methodology that accounts for misclassification of 6	
an exposure reduced the magnitude of the mediation effect at all three significant loci, 7	
suggesting that these results need validation using an alternative approach such as 8	
Mendelian Randomisation (51).  9	
While we explored whether DNA methylation lies on the causal pathway between maternal 10	
smoking and low birth weight, results from EWAS analyses do not distinguish cause from 11	
effect. In fact, it is likely that the DNA methylation differences we report for birth weight and 12	
gestational age reflect other in utero exposures or processes. For example birth weight is 13	
known to be associated with maternal body mass index, blood pressure and fasting glucose 14	
levels (52-54) and the epigenetic changes we report may reflect the downstream influences 15	
of these pathways. It is also possible that the birth-weight-associated DMPs identified in our 16	
study reflect exposures or influences occurring in the immediate neonatal period before the 17	
blood samples were collected. Similarly, the DNA methylation differences observed in 18	
neonates exposed to prenatal smoking might also be influenced by exposure to passive 19	
smoking from the mother or father immediately after birth, although the amount of exposure 20	
in ~6 days is likely to be negligible. Another potential limitation of our design is that the 21	
analyses were performed within the context of an autism case-control study (32). Of note, 22	
however, although autism cases had a higher exposure to maternal smoking than non-23	
autism controls, there was not significant difference in birth weight between infants who went 24	
on to develop autism than those who did not (Supplementary Table 1). Finally, the nature 25	
of the samples we profiled in this study (i.e. small amounts of neonatal blood) meant that 26	
additional DNA was not available for technical validation experiments. However, the Illumina 27	
450K array has been shown to yield highly reproducible measures of DNA methylation, and 28	
the observed consistency with previous studies of maternal smoking, gestational age, and 29	
birth weight suggests our findings are robust. 30	
 31	
Conclusions 32	
Our data demonstrate that in utero exposures are associated with detectable patterns of 33	
DNA methylation in neonatal blood samples, highlighting the role that the prenatal 34	
environment plays in influencing gene regulation in neonates.  While previous studies have 35	
	 16	
shown that maternal smoking effects persist into later childhood (13), these have found that 1	
the effects are attenuated, suggesting that obtaining a biomarker as close to birth as 2	
possible will have maximal sensitivity about exposures during gestation.  3	
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Tables 
Table 1. DNA methylation in neonatal blood is associated with birth weight and gestational age. In total, seven differentially methylated 
positions (DMPs) were associated with both birth weight and gestational age at an experiment-wide threshold of P < 1x10-7. Genomic locations 
are based on hg19. 
 
ProbeID 
EWAS of birth weight (g) EWAS of gestational age (weeks) 
Chr Pos 
Gene Annotation 
 P-value Regression coefficient  P-value Regression coefficient UCSC Gene Name UCSC Genic Region 
cg04411893 9.88E-08 -8.41E-06 2.28E-12 -0.003758699 chr3 185300709     
cg05937055 4.66E-09 -1.20E-05 5.20E-10 -0.004302303 chr1 181128764     
cg06870470 2.97E-09 -1.68E-05 6.93E-28 -0.01068899 chr19 11315767 DOCK6 Body 
cg13066703 2.50E-08 -1.11E-05 3.68E-36 -0.008742825 chr1 211526705 TRAF5 Body 
cg19744173 1.87E-10 -1.41E-05 8.41E-20 -0.006889143 chr2 112913178 FBLN7 Body 
cg20068209 5.19E-08 -1.37E-05 2.00E-41 -0.011959147 chr6 75988568 TMEM30A Body 
cg20076442 1.18E-10 -1.96E-05 3.23E-25 -0.010843225 chr8 72745197     
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Table 2. Three DNA methylation sites meet the criteria for significant mediation between birth weight and maternal smoking. 
 
ProbeID Chr Pos Gene Annotation 
Birth weight ~ 
maternal smoking 
EWAS of maternal 
smoking EWAS of birth weight 
EWAS of birth weight 
adjusted for maternal 
smoking Sobel 
test P-
value P-
value 
Regression 
coefficient 
P-
value 
Regression 
coefficient 
P-
value 
Regression 
coefficient P-value 
Regression 
coefficient 
cg09935388 chr1 92947588 GFI1 3.21E-14 -282.418 
1.39E-
55 -0.1208 
2.58E-
08 4.18E-05 2.72E-08 -229.556 
3.58E-
09 
cg05575921 chr5 373378 AHRR 3.21E-14 -282.418 
8.29E-
119 -0.08196 
1.17E-
10 2.37E-05 0.000151 -178.772 
8.52E-
14 
cg26889659 chr6 684090 EXOC2 3.21E-14 -282.418 
7.42E-
13 -0.03981 
3.84E-
08 2.89E-05 2.41E-10 -238.068 
1.12E-
06 
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Figure Captions 
Figure 1. Methylomic variation associated with birth weight and gestational age in 
neonates. Manhattan plots of P-values from an epigenome-wide association study (EWAS) 
of A) birth weight (g) and B) gestational age (weeks). The red horizontal line indicates 
experiment-wide significance (P < 1x10-7), the blue horizontal line indicates a ‘discovery’ 
significance threshold (P < 5x10-5). Shown are scatterplots of the top-ranked differentially 
methylated positions (DMPs) associated with C) birth weight (cg20076442) and D) 
gestational age (cg11932158).  
 
Figure 2. DNA methylation at birth is associated with maternal smoking during 
pregnancy. The red horizontal line indicates experiment-wide significance (P < 1x10-7), the 
blue horizontal line indicates a ‘discovery’ significance threshold (P < 5x10-5). A) Manhattan 
plots from an EWAS of maternal smoking. Boxplots of the three top-ranked DNA methylation 
sites associated with maternal smoking: B) cg05575921, C) cg09935388 and D) 
cg12803068. Shown are unadjusted DNA methylation values. 
 
Supplementary Table Captions (see Excel file for Supplementary Tables). 
Supplementary Table 1. Characteristics of samples included in the MINERvA cohort. * 
= primary characteristics used to match cases and controls. ** = secondary characteristics 
used to match cases and controls as closely as possible. 
 
Supplementary Table 2. Eighteen birth weight associated DMPs were identified at a 
threshold of P < 1x10-7. Genomic locations are based on hg19. 
 
Supplementary Table 3. 4,299 gestational age associated DMPs were identified at a 
threshold of P < 1x10-7. Genomic locations are based on hg19. 
 
Supplementary Table 4. Conditional analysis within 3,550 distinct loci associated with 
gestational age. 
 
Supplementary Table 5. 110 maternal smoking associated DMPs were identified at a 
threshold of P < 1x10-7. Genomic locations are based on hg19. 
 
Supplementary Table 6. Conditional analysis within 70 distinct loci associated with 
maternal smoking. 
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Supplementary Table 7. 143 DMPs associated with maternal smoking selected for 
mediation analysis. 
 
Supplementary Table 8. SIMEX adjusted mediation analysis for 3 DNA methylation 
sites identified as having significant mediation effects between maternal smoking and 
birth weight. 
 
